
Current Clinical Trials
Stress Urinary Incontinence
You may be able to take part in the study if you are:
-
Are a woman at least 18 years of age,
-
Still experience urine leakage on effort or exertion, or on sneezing or coughing, at least 2 times a day after surgical treatment,
-
Have tried pelvic floor muscle training (PFMT) and received a surgical treatment for SUI, which didn’t resolve your symptoms.
​
​
​
​​​​​​​​​​​​Stress Urinary Incontinence
Females ages 18-55 diagnosed with stress urinary incontinence with no history of prior treatment may be eligible.
​
​
​
Bladder Cancer
A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Subjects with Intermediate Risk (IR) Non-Muscle Invasive Bladder Cancer (NMIBC).
The subjects must have undergone adequate Transurethral Resection of Bladder Tumor (TURBT) during screening with or without peri-operative intravesical chemotherapy within 60 days prior randomization, and must have one of the following, confirmed by a diagnostic pathology report:
-
Recurrence within 1 year, low-grade Ta
-
Solitary low-grade Ta >3 cm
-
Low-grade Ta, multifocal
-
High-grade Ta, ≤3 cm
-
Low-grade T1
​​
​
​
​​
​Urinary Tract Infection
​Selected participation criteria:​
-
Women between the ages 18-75
-
Have had at least one UTI in past 12 months
-
Have a current UTI
​​
​
​
​
​​​To see if you qualify for one of the above trials, please send us an email.